Amin Khan - 12 Jun 2023 Form 3 Insider Report for Icosavax, Inc.

Role
EVP, Head of Research & Dev.
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
12 Jun 2023
Net transactions value
$0
Form type
3
Filing time
14 Jun 2023, 19:40:43 UTC
Previous filing
08 Aug 2022
Next filing
20 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ICVX Stock Option (Right to Buy) 12 Jun 2023 Common Stock 120,000 $9.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option will vest on February 15, 2024, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service through the applicable vesting date.